Xilio Therapeutics News

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brennan Kevin M.

Oct 2 17:19 ET

Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-GKCC, LLC(15.9%),Yekaterina Chudnovsky(15.9%)

Sep 27 21:39 ET

Xilio Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Chudnovsky Yekaterina

Sep 27 21:04 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Frankenfield Christopher James

Aug 6 20:03 ET

Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(4%),Takeda Ventures, Inc(4%)

Jul 31 07:51 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bonstein Sara

Jun 17 16:39 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Xu Yuan

Jun 17 16:39 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROSS ROBERT W.

Jun 17 16:38 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rossi Christina

Jun 17 16:38 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clancy Paul J

Jun 17 16:37 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Curran Daniel J.

Jun 17 16:37 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shannon James Samuel

Jun 17 16:19 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Brennan Aoife

Jun 17 16:17 ET

Xilio Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Shannon James Samuel

Jun 17 16:16 ET

Xilio Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Brennan Aoife

Jun 17 16:13 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Russo Rene

May 3 16:13 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Frankenfield Christopher James

May 3 16:13 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brennan Kevin M.

May 3 16:12 ET

Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luptakova Katarina

May 3 16:12 ET

Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(19.9%)

Apr 5 16:36 ET